wpengine

About wpengine

This is the "wpengine" admin user that our staff uses to gain access to your admin area to provide support and troubleshooting. It can only be accessed by a button in our secure log that auto generates a password and dumps that password after the staff member has logged in. We have taken extreme measures to ensure that our own user is not going to be misused to harm any of our clients sites.
6 02, 2020

St. Louis biotech startup raises $25M as it prepares for commercialization

2020-02-06T14:03:46-06:00February 6th, 2020|

Adarza BioSystems said the funding will help it prepare for commercialization of its ZIVA platform, a biological testing device designed to assist researchers with disease profiling and drug development.

23 05, 2018

St. Louis Business Journal: St. Louis biotech startup to launch products in 2019

2018-05-23T15:23:03-05:00May 23rd, 2018|

Once Adarza's products launch in the second quarter of 2019, it will be one of a handful of local life sciences startups to have done so.

24 01, 2017

St. Louis Business Journal: RiverVest leads $17M investment in Adarza, brings on new president

2017-09-11T12:53:54-05:00January 24th, 2017|

RiverVest leads $17 million investment in Adarza, brings on new president

19 01, 2017

ADARZA BIOSYSTEMS CLOSES ON $17 MILLION SERIES C FINANCING

2018-05-02T01:29:44-05:00January 19th, 2017|

ROCHESTER, NY and ST LOUIS, MO (Jan. 19, 2017) – Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in its St. Peters, MO manufacturing facility and fund final development and commercialization of Adarza’s first immunoassay product consumable and instrument platform. Adarza develops and manufactures immunoassay technology that can identify proteins and genetic markers in medical samples such as blood. The technology, which comes in the form of microchips, [...]

16 01, 2017

Event Update

2017-09-11T12:54:27-05:00January 16th, 2017|

  Join us at the 15th Cytokines & Inflammation Conference, February 6-7, 2017 in San Diego, CA. Booth #6. And check our poster while you’re there: “A Multiplex Panel for Simultaneously Profiling Toxicant Levels and Biological Response Indicators in Serum Samples”.

6 09, 2016

Senior QC Manager

2018-05-02T01:29:44-05:00September 6th, 2016|

Adarza BioSystems, Inc. is a venture capital backed biotechnology company developing label-free protein microarray assays based on the Company’s proprietary Arrayed Imaging Reflectometry (AIR™) platform.  Adarza is seeking a Quality Manager to implement our QMS and lead the ISO 9001:2015 certification process.  Reporting to the Head of Missouri Operations, this individual will have an opportunity to develop and grow with a dynamic, emerging company in the greater St. Louis, MO area. Job Description: The position requires proven expertise in creating and maintaining a Quality Management system, starting with the Quality Policy and then translating [...]

24 03, 2016

Adarza BioSystems Completes $5 M Series-B Closing

2018-05-02T01:29:44-05:00March 24th, 2016|

ROCHESTER, N.Y. ST LOUIS, MO – Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed a $5 M Series B financing. Proceeds from the financing will be used to expand production capacity in its St. Peters, MO manufacturing facility and launch its first immunoassay product consumable and instrument platform. Proceeds will also be used to accelerate development of highly sensitive assays targeting a variety of biological analytes including cytokines, antigens and small molecules. Adarza’s Arrayed Imaging Reflectometry (AIRstrip™) will bring an unprecedented combination of performance, [...]

25 11, 2014

Horizon Discovery Group plc and Adarza BioSystems Enter Supply & Licensing Agreement

2018-05-02T01:29:44-05:00November 25th, 2014|

Agreement gives Horizon exclusive right to supply services on Ardaza’s multiplex label-free immunoassay technology.

24 10, 2014

Adarza BioSystems Selects SunEdison Semiconductor Site for Manufacturing Immunoassay Consumables

2018-05-02T01:29:44-05:00October 24th, 2014|

Adarza BioSystems, Inc. has executed an agreement with SunEdison Semiconductor to establish immunoassay consumable manufacturing facilities at its St. Peters, Missouri manufacturing site.